Innovation During Disruption and Change

We live in times of disruption and change.

• Technology is disruptive. Digital and mobile technologies, in particular, continue to significantly change how we communicate and how we do business.
• Medicine and science are disruptive by nature. They test the boundaries of knowledge to expand the possibilities for humankind.
• The political environment is disruptive. The 21st Century Cures Act is going into effect, and the new administration in Washington is making a great many changes in its first few weeks. A repeal of the Affordable Care Act is planned, as well as other changes to healthcare access and priorities.
• Even our current demographics are disruptive. The Baby Boomer generation is aging toward retirement; the even-larger Millennial generation has reached adulthood; and America’s diverse makeup is growing ever more varied.

The pharmaceutical industry, staid and traditionally risk-averse because of its serious purpose and its highly regulated processes, looks positively upon on innovation, but it doesn’t always take well to disruption. In this article for Intouch Solutions, I look at the changes we’re currently facing and the trends associated with those changes, and hear what several Intouch experts have to say about how the expected changes will affect pharma and pharma marketers.